STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

HEALTH RESEARCH INCORPORATED ELIZABETH WOOD: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
HEALTH RESEARCH INCORPORATED ELIZABETH WOOD (EIN 14-1402155)
Tax period
2020-04-01 to 2021-03-31
Filed
2021-08-16
IRS object ID
202102289349300010
Schema version
2020v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-08-16T08:39:13-05:00ReturnTs
Tax Period End2021-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN161131146PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BONADIO & CO LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line16 WEMBLEY CTAddressLine1Txt
CityALBANYCityNm
State AbbreviationNYStateAbbreviationCd
ZIP12205ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2020-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN141402155EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1HEALTH RESEARCH INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlHEALBusinessNameControlTxt
Phone5184311200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1150 BROADWAY NO 280AddressLine1Txt
CityMENANDSCityNm
State AbbreviationNYStateAbbreviationCd
ZIP12204ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonCHERYL A MATTOXPersonNm
Person TitleEXECUTIVE DIRECTORPersonTitleTxt
Phone5184311200PhoneNum
Signature2021-08-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstCHERYLPersonFirstNm
Person LastMATTOXPersonLastNm
FieldValueIRS element (for citing)
SSNXXX-XX-XXXXSSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJUDITH J SOROPreparerPersonNm
PTINP00743262PTIN
Phone5184644080PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd
Principal OfficerCHERYL A MATTOXPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1150 BROADWAY NO 280AddressLine1Txt
CityMENANDSCityNm
State AbbreviationNYStateAbbreviationCd
ZIP12204ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$1,664,620,390GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.HEALTHRESEARCH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1953FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionSEE SCHEDULE O.ActivityOrMissionDesc
Voting Members Governing Body6VotingMembersGoverningBodyCnt
Voting Members Independent2VotingMembersIndependentCnt
Total Employee2430TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,311,261,527PYContributionsGrantsAmt
CY Contributions Grants$1,151,309,750CYContributionsGrantsAmt
PY Program Service Revenue$194,899PYProgramServiceRevenueAmt
CY Program Service Revenue$159,745CYProgramServiceRevenueAmt
PY Investment Income$14,849,074PYInvestmentIncomeAmt
CY Investment Income$10,083,875CYInvestmentIncomeAmt
PY Other Revenue$214,436PYOtherRevenueAmt
CY Other Revenue$179,285CYOtherRevenueAmt
PY Total Revenue$1,326,519,936PYTotalRevenueAmt
CY Total Revenue$1,161,732,655CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$189,247,002PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$203,213,234CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$631,097,918PYOtherExpensesAmt
CY Other Expenses$976,061,370CYOtherExpensesAmt
PY Total Expenses$820,344,920PYTotalExpensesAmt
CY Total Expenses$1,179,274,604CYTotalExpensesAmt
PY Revenues Less Expenses$506,175,016PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$17,541,949CYRevenuesLessExpensesAmt
Total Assets BOY$760,960,393TotalAssetsBOYAmt
Total Assets EOY$806,598,865TotalAssetsEOYAmt
Total Liabilities BOY$143,784,309TotalLiabilitiesBOYAmt
Total Liabilities EOY$195,951,181TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$617,176,084NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$610,647,684NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$535,708,400ExpenseAmt
DescHIV UNINSURED PROGRAMS SEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$401,739,528ExpenseAmt
DescPUBLIC HEALTH EMERGENCY PREPAREDNESS AND HOSPITAL PREPAREDNESSSEE SCHEDULE ODesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$123,675,385ExpenseAmt
DescCANCER RESEARCH SEE SCHEDULE ODesc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$81,274,390ExpenseAmt
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$81,274,390TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses$1,142,397,703TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document305IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee2430EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members6GoverningBodyVotingMembersCnt
Independent Voting Member2IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonTERESA MAKAROWSKY CONTROLLERPersonNm
Phone5184311200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1150 BROADWAY SUITE 280AddressLine1Txt
CityMENANDSCityNm
State AbbreviationNYStateAbbreviationCd
ZIP12204ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
CHERYL MATTOX
EXECUTIVE DIRECTOR38.00Yes (X)Yes (X)$160,655$0$52,304
HOWARD ZUCKER MD
PRESIDENT2.00Yes (X)Yes (X)$66,958$0$9,441
CANDACE JOHNSON
DIRECTOR0.20Yes (X)$0$0$0
TIM REYNOLDS CPA
DIRECTOR0.20Yes (X)$0$0$0
JUSTIN RUNKE ESQ
DIRECTOR0.20Yes (X)$0$0$0
MICHAEL SEXTON ESQ
DIRECTOR0.20Yes (X)$0$0$0
ANDREW RUBY
SECRETARY/TREASURER2.00Yes (X)Yes (X)$0$0$0
TERESA MAKAROWSKY CPA
CORPORATE CONTROLLER38.00Yes (X)$133,262$0$48,144
MARY E REID
CHIEF, CANCER SCREENING & SURVIVOR38.00$279,068$0$69,451Yes (X)
CHARLES GONZALEZ
MEDICAL DIRECTOR, AI38.00$189,966$0$56,177Yes (X)
VIRGINIA L FILIACI
CHIEF, CLINICAL TRIAL DEVE38.00$187,616$0$39,547Yes (X)
STEVEN J ROSTERN
MGR, HLTH EMERG PREPAREDNESS38.00$217,932$0$59,602Yes (X)
HANS MINDERMAN
ASSOC DIR., FLOW CYTOMETRY RES38.00$181,036$0$50,964Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,416,493TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$385,630TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K248IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
OPAD MEDIA SOLUTIONS LLC
275 MADISON AVENUE 22ND FLOORNEW YORKNY10016CONSULTANT$2,212,608
WINDSONG RADIOLOGY GROUP
55 SPINDRIFT DRIVEWILLIAMSVILLENY14221CONSULTANT$797,961
HODGSON RUSS LLP
1 MT PLAZA SUITE 2000BUFFALONY14203CONSULTANT$481,719
HEALTHPLUS HP LLC
9 PINE STREET 14TH FLOORNEW YORKNY10005CONSULTANT$252,696
WHITEMAN OSTERMAN & HANNA
ONE COMMERCE PLAZAALBANYNY12260CONSULTANT$177,277
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K9CntrctRcvdGreaterThan100KCnt
Government Grants$710,234,527GovernmentGrantsAmt
All Other Contributions$441,075,223AllOtherContributionsAmt
Noncash Contributions$9,173,071NoncashContributionsAmt
Total Contributions$1,151,309,750TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescCONTRACT FEESDesc
Business541900BusinessCd
Total Revenue Column$159,745TotalRevenueColumnAmt
Exclusion$159,745ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$159,745TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$7,994,059TotalRevenueColumnAmt
Exclusion$7,994,059ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$179,285TotalRevenueColumnAmt
Exclusion$179,285ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$504,977,551SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$502,887,735SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$2,089,816SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,089,816TotalRevenueColumnAmt
Exclusion$2,089,816ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,161,732,655TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$10,422,905ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$447,501TotalAmt
Management And General$447,501ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$148,875,518TotalAmt
Program Services$129,037,933ProgramServicesAmt
Management And General$19,837,585ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$18,025,510TotalAmt
Program Services$15,625,039ProgramServicesAmt
Management And General$2,400,471ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$25,386,720TotalAmt
Program Services$21,902,786ProgramServicesAmt
Management And General$3,483,934ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$10,477,985TotalAmt
Program Services$9,056,925ProgramServicesAmt
Management And General$1,421,060ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$316,211TotalAmt
Program Services$118,044ProgramServicesAmt
Management And General$198,167ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$146,800TotalAmt
Management And General$146,800ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$66,176TotalAmt
Management And General$66,176ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$4,917,537TotalAmt
Program Services$4,260,428ProgramServicesAmt
Management And General$657,109ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$57,730,273TotalAmt
Program Services$56,758,408ProgramServicesAmt
Management And General$971,865ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,620,570TotalAmt
Program Services$1,798,487ProgramServicesAmt
Management And General$822,083ManagementAndGeneralAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$72,338TotalAmt
Program Services$72,338ProgramServicesAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,500,188TotalAmt
Program Services$21,231ProgramServicesAmt
Management And General$3,478,957ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$491,930TotalAmt
Program Services$481,300ProgramServicesAmt
Management And General$10,630ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$143,764TotalAmt
Program Services$143,764ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$240,724TotalAmt
Management And General$240,724ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$706,902TotalAmt
Management And General$706,902ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
PROGRAM COSTS$456,356,505$456,356,505
SUBCONTRACTS$437,397,696$436,207,812$1,189,884
TUITION, TRAINING, AND$1,869,328$1,815,294$54,034
PRINTING AND PUBLICATIO$1,130,249$540,854$589,395

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$8,354,179TotalAmt
Program Services$8,200,555ProgramServicesAmt
Management And General$153,624ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$1,179,274,604TotalAmt
Program Services$1,142,397,703ProgramServicesAmt
Management And General$36,876,901ManagementAndGeneralAmt
Fundraising$0FundraisingAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XYes (X)InfoInScheduleOPartXInd

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$154,538,031BOYAmt
EOY$96,485,953EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$64,205,209BOYAmt
EOY$115,597,444EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,845,249BOYAmt
EOY$1,924,864EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$478,682BOYAmt
EOY$404,358EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$4,352,190LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$3,416,892LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$884,562BOYAmt
EOY$935,298EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$510,057,272BOYAmt
EOY$572,410,944EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$28,951,388BOYAmt
EOY$18,840,004EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$760,960,393BOYAmt
EOY$806,598,865EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$76,878,575BOYAmt
EOY$127,858,975EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$37,954,346BOYAmt
EOY$49,252,202EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$28,951,388BOYAmt
EOY$18,840,004EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$143,784,309BOYAmt
EOY$195,951,181EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$123,021,844BOYAmt
EOY$131,647,201EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$494,154,240BOYAmt
EOY$479,000,483EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$617,176,084BOYAmt
EOY$610,647,684EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$760,960,393BOYAmt
EOY$806,598,865EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$17,541,949ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$11,013,549NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$683,250,315CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$704,248,802CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$758,412,389CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,311,261,527CurrentTaxYearMinus1YearAmt
Current Tax Year$1,151,309,749CurrentTaxYearAmt
Total$4,608,482,782TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$683,250,315CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$704,248,802CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$758,412,389CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,311,261,527CurrentTaxYearMinus1YearAmt
Current Tax Year$1,151,309,749CurrentTaxYearAmt
Total$4,608,482,782TotalAmt
FieldValueIRS element (for citing)
Public Support Total170$4,608,482,782PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,462,317CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$7,291,691CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,546,508CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$15,355,775CurrentTaxYearMinus1YearAmt
Current Tax Year$8,260,752CurrentTaxYearAmt
Total$48,917,043TotalAmt
FieldValueIRS element (for citing)
Total Support$4,657,399,825TotalSupportAmt
Public Support CY1700.98950PublicSupportCY170Pct
Public Support PY1700.98930PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$31,672BeginningYearBalanceAmt
Investment Earnings Or Losses$151InvestmentEarningsOrLossesAmt
End Year Balance$31,823EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$624,319BeginningYearBalanceAmt
Investment Earnings Or Losses$8,684InvestmentEarningsOrLossesAmt
Other Expenditures-$601,331OtherExpendituresAmt
End Year Balance$31,672EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$612,804BeginningYearBalanceAmt
Investment Earnings Or Losses$11,515InvestmentEarningsOrLossesAmt
End Year Balance$624,319EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$607,286BeginningYearBalanceAmt
Investment Earnings Or Losses$5,518InvestmentEarningsOrLossesAmt
End Year Balance$612,804EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$605,120BeginningYearBalanceAmt
Investment Earnings Or Losses$2,166InvestmentEarningsOrLossesAmt
End Year Balance$607,286EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY1.00000BoardDesignatedBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$21,697OtherCostOrOtherBasisAmt
Depreciation$21,697DepreciationAmt
Book Value$0BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$550,595OtherCostOrOtherBasisAmt
Depreciation$148,963DepreciationAmt
Book Value$401,632BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,779,898OtherCostOrOtherBasisAmt
Depreciation$3,246,232DepreciationAmt
Book Value$533,666BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$935,298TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescAGENCY FUND - SEE PART XIIIDesc
Amt$18,840,004Amt
FieldValueIRS element (for citing)
Total Liability$18,840,004TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$1,172,673,865TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$11,013,548NetUnrealizedGainsInvstAmt
Revenue Not Reported$11,013,548RevenueNotReportedAmt
Revenue Subtotal$1,161,660,317RevenueSubtotalAmt
Other Revenues Not Included$72,338OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$72,338RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$1,161,732,655TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$1,179,202,266TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$1,179,202,266ExpensesSubtotalAmt
Other Expenses Not Included$72,338OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$72,338ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$1,179,274,604TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART XI, LINE 4B - OTHER ADJUSTMENTS:ROYALTIES PAID TO INVENTORS 72,338.
PART XII, LINE 4B - OTHER ADJUSTMENTS:ROYALTIES PAID TO INVENTORS 72,338.
PART V, LINE 4QUASI ENDOWMENTS WERE ESTABLISHED TO FURTHER RESEARCH AT HELEN HAYES HOSPITAL, PROVIDE AWARDS TO RISING SCIENTISTS FOR OUTSTANDING CREATIVITY AND QUALITY OF CONTRIBUTION OF BASIC RESEARCH AND FOR LITERATURE AND ARTS OF SCIENCES FOR THE WADSWORTH CENTER LIBRARY. IN JUNE 2019 THE BOARD OF DIRECTORS APPROVED THE RECLASSIFICATION OF THREE OF THE QUASI ENDOWMENTS. THE RECLASSIFICATION ALLOWED THESE FUNDS TO BE MADE AVAILABLE TO THE INTENDED PROGRAMS. THE RECLASSIFICATION IS SHOWN ON LINE 1E FOR 2019.
PART X, LINE 2AGENCY FUNDS THE CORPORATION IS ADMINISTERING ON BEHALF OF THE OFFICE OF THE ATTORNEY GENERAL, NEW YORK STATE DEPARTMENT OF LAW (OAG), PURSUANT TO A FUNDING ADMINISTRATION AGREEMENT.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Substantiation RequiredYes (1)SubstantiationRequiredInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MARY E REID
CHIEF, CANCER SCREENING & SURVIVOR$279,068$0$0$0$0$0$44,930$0$24,521$0$348,519$0$0$0
STEVEN J ROSTERN
MGR, HLTH EMERG PREPAREDNESS$217,932$0$0$0$0$0$36,053$0$23,549$0$277,534$0$0$0
CHARLES GONZALEZ
MEDICAL DIRECTOR, AI$189,966$0$0$0$0$0$30,584$0$25,593$0$246,143$0$0$0
HANS MINDERMAN
ASSOC DIR., FLOW CYTOMETRY RES$181,036$0$0$0$0$0$29,147$0$21,817$0$232,000$0$0$0
VIRGINIA L FILIACI
CHIEF, CLINICAL TRIAL DEVE$170,791$0$0$0$16,825$0$30,206$0$9,341$0$227,163$0$0$0
CHERYL MATTOX
EXECUTIVE DIRECTOR$135,708$0$0$0$24,947$0$25,865$0$26,439$0$212,959$0$0$0
TERESA MAKAROWSKY CPA
CORPORATE CONTROLLER$128,957$0$0$0$4,305$0$21,455$0$26,689$0$181,406$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART II, COLUMN B (II) - BONUS & INCENTIVE COMPENSATIONPRINCIPAL INVESTIGATORS (PI) WORKING WITH THE BUFFALO DIVISION MAY BE ELIGIBLE FOR SALARY RECOVERY DISTRIBUTIONS ANNUALLY. THE PI'S PERFORMANCE IS REVIEWED AGAINST SPECIFIC GUIDELINES AND RECOMMENDATIONS ARE MADE BY THE COMMITTEE ON THE DISTRIBUTION OF SALARY RECOVERY SUPPORT.
PART II, COLUMN B (III) - OTHER REPORTABLE COMPENSATIONTHIS AMOUNT REPRESENTS EMPLOYEE CONTRIBUTIONS OF THEIR BASE COMPENSATION TO AN INDIVIDUAL DEFERRED COMPENSATION PLAN.

Schedule M IRS990ScheduleM

Drugs And Medical Supplies DrugsAndMedicalSuppliesGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution78ContributionCnt
Noncash Contributions Rpt F990$9,173,071NoncashContributionsRptF990Amt
Method Of Determining RevenuesSELLING PRICEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (13 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1, ORGANIZATION'S MISSION:ADMINISTER GIFTS AND GRANTS IN KEEPING WITH THE HEALTH RESEARCH, PREVENTION AND TREATMENT PURPOSE OF THE NYS DEPARTMENT OF HEALTH, THE ROSWELL PARK CANCER INSTITUTE CORPORATION AND OTHER HEALTH RELATED PUBLIC AND PRIVATE ENTITIES; ALSO INCLUDING INTELLECTUAL PROPERTY MANAGEMENT AND TECHNOLOGY TRANSFER.
990, PART I, LINE 1, SIGNIFICANT ACTIVITIESTHE FOLLOWING AWARDS HIGHLIGHT A FEW OF THE MANY SPONSORED PROJECTS THAT HEALTH RESEARCH, INC HAS RECEIVED FUNDING FOR DURING THE REPORTING PERIOD: CONTACT TRACING ACCELERATION INITIATIVE VITAL STRATEGIES AWARD RECEIVED IN MAY 2020 TO ASSIST WITH IMPLEMENTING STAFFING AND CONTRACTUAL SERVICES NECESSARY TO ESTABLISH COVID-19 CONTACT TRACING EFFORTS IN THE WESTCHESTER AND SUFFOLK COUNTY HEALTH DEPARTMENTS. HRI PROVIDED DIRECT ASSISTANCE BY HIRING THE NECESSARY STAFF, PLACED IN WESTCHESTER AND SUFFOLK COUNTY HEALTH DEPARTMENTS, TO IMPLEMENT CRUCIAL CONTACT TRACING EFFORTS. CORONAVIRUS STATE HOSPITAL IMPROVEMENT PROGRAM HEALTH RESOURCES AND SERVICES ADMINISTRATION AWARD RECEIVED TO SUPPORT THE SMALL HOSPITAL IMPROVEMENT PROGRAM'S CONTINUED EFFORTS TO ADDRESS THE NEEDS OF PROVIDING HEALTH SERVICES TO RURAL AND UNDERSERVED COMMUNITIES AFFECTED BY COVID-19. FUNDS CAN BE USED FOR SEVERAL REASONS INCLUDING, BUT NOT LIMITED TO, PURCHASING PPE, IMPLEMENT EMERGENCY OPERATIONS PLANS, PURCHASE AND INSTALLATION OF TEMPORARY BARRIERS TO SUPPORT APPROPRIATE DISTANCING, ENHANCE OR INSTALL VENTILATION SYSTEMS TO PROMOTE FACILITY AIR QUALITY AND EMBEDDING CDC GUIDANCE INTO ELECTRONIC HEALTH RECORD CLINICAL DECISION SUPPORT TOOLS. EPIDEMIOLOGY AND LABORATORY CAPACITY - COVID SUPPLEMENTS ENHANCING DETECTION ENHANCING DETECTION EXPANSION CENTERS FOR DISEASE CONTROL AND PREVENTION THESE SUPPLEMENTAL AWARDS SUPPORT NECESSARY EXPENSES TO IMPLEMENT AND OVERSEE EXPANDED TESTING CAPACITY FOR COVID-19/SARS-COV-2, INCLUDING THE ABILITY TO PROCESS, MANAGE, ANALYZE, USE, AND REPORT THE INCREASED DATA PRODUCED. AWARDEES WILL ESTABLISH A ROBUST SARS-COV-2 TESTING PROGRAM THAT ENSURES ADEQUATE TESTING IS MADE AVAILABLE ACCORDING TO CDC PRIORITIES, INCLUDING BUT NOT LIMITED TO: DIAGNOSTIC TESTS, TESTS FOR CONTACT TRACING, AND SURVEILLANCE OF ASYMPTOMATIC PERSONS TO DETERMINE COMMUNITY SPREAD. AS AN AWARDEE, HRI/DOH MUST ENSURE THAT PROVISIONS ARE IN PLACE TO MEET FUTURE SURGE CAPACITY TESTING NEEDS INCLUDING POINT OF CARE OR OTHER RAPID RESULT TESTING FOR LOCAL OUTBREAKS. ADDITIONAL RESOURCES (EXPANSION) ARE INTENDED TO PREVENT, PREPARE FOR, AND RESPOND TO CORONAVIRUS BY SUPPORTING TESTING, CASE INVESTIGATION AND CONTACT TRACING, SURVEILLANCE, CONTAINMENT, AND MITIGATION. SUCH ACTIVITIES MAY INCLUDE SUPPORT FOR WORKFORCE, EPIDEMIOLOGY, USE BY EMPLOYERS, ELEMENTARY AND SECONDARY SCHOOLS, CHILD CARE FACILITIES, INSTITUTIONS OF HIGHER EDUCATION, LONG-TERM CARE FACILITIES, OR IN OTHER SETTINGS, SCALE UP OF TESTING BY PUBLIC HEALTH, ACADEMIC, COMMERCIAL, AND HOSPITAL LABORATORIES, AND COMMUNITY-BASED TESTING SITES, MOBILE TESTING UNITS, HEALTH CARE FACILITIES, AND OTHER ENTITIES ENGAGED IN COVID19 TESTING, AND OTHER ACTIVITIES RELATED TO COVID19 TESTING, CASE INVESTIGATION AND CONTACT TRACING, SURVEILLANCE, CONTAINMENT, AND MITIGATION (INCLUDING INTERSTATE COMPACTS OR OTHER MUTUAL AID AGREEMENTS FOR SUCH PURPOSES). HIGH-THROUGHPUT DRIED BLOOD SPOT TECHNOLOGIES IN SARS COV-2 SEROLOGY AND VACCINOLOGY NATIONAL CANCER INSTITUTE THE AWARD IS FOCUSED ON IMPROVING OUR ABILITY TO ASSESS PROTECTIVE ANTIBODY RESPONSES IN RESPONSE TO SARS COV-2 INFECTION AND VACCINATION. THE PROJECT IS A COLLABORATION BETWEEN DIFFERENT LABORATORIES WITHIN THE WADSWORTH CENTER. THE CENTRAL THRUST OF THE PROJECT TAKES ADVANTAGE OF HIGH THROUGHPUT TECHNOLOGIES TO PROFILE ANTIBODIES IN DRIED BLOOD SPOTS (DBS) THAT HAVE BEEN EMPLOYED IN THE BLOODBORNE DISEASE LAB. IN AIM 1, THE ESTABLISHED DBS METHODOLOGY WILL BE EXPANDED TO ENCOMPASS THE BREADTH OF ANTIBODY CLASSES IN BLOOD. IN AIM 2, PROJECT STAFF WILL EVALUATE THE FEASIBILITY OF PERFORMING FUNCTIONAL ASSAYS WITH DBS. AIM 3 WILL EXAMINE MUCOSAL ANTIBODY RESPONSES TO SARS COV-2 INFECTION.
990, PART III, LINE 4A. FEDERALLY FUNDED HIV AIDS PREVENTION AND CARETHE UNINSURED CARE PROGRAMS (UCP) PROVIDE MEDICATIONS AND MEDICAL CARE TO UNINSURED AND UNDERINSURED NEW YORK STATE RESIDENTS LIVING WITH OR AT RISK OF ACQUIRING HIV/AIDS. LINKING PEOPLE WITH HIV TO TREATMENT IN ORDER TO IMPROVE HEALTH AND ACHIEVE VIRAL SUPPRESSION IS A PRIMARY GOAL OF THE AIDS INSTITUTE, A KEY GOAL OF THE INTEGRATED PLAN/SCSN, AND ONE OF THE FUNDAMENTAL TENETS OF NEW YORK STATE'S ETE INITIATIVE. THE UCP ENSURE UNIVERSAL ACCESS TO CARE AND TREATMENT THAT ARE ESSENTIAL TO IMPROVE HEALTH OUTCOMES, ACHIEVE VIRAL SUPPRESSION, AND REDUCE THE RISK OF TRANSMISSION. THE UCP ADDRESS GAPS IN AND BARRIERS TO CARE AND IMPROVE OUTCOMES ALONG THE CONTINUUM, INCLUDING LINKAGE TO CARE AND VIRAL SUPPRESSION. THE UCP ARE KEY COMPONENTS IN NEW YORK'S RESPONSE TO THE HIV/AIDS EPIDEMIC. NEW YORK STATE'S UCP ARE THE MOST COMPREHENSIVE IN THE NATION, OFFERING A FULL SCOPE OF SERVICES TO PERSONS WITH HIV/AIDS. THROUGH PARTNERSHIPS BETWEEN THE STATE AND FEDERAL GOVERNMENTS AND BETWEEN THE STATE AND THE NEW YORK CITY AND LONG ISLAND RYAN WHITE PART A REGIONS. THE UCP SERVES OVER 24,000 UNINSURED AND UNDERINSURED PERSONS LIVING WITH HIV/AIDS ANNUALLY. THE MAJORITY OF ADAP PARTICIPANTS ARE PERSONS OF COLOR: 37.6 PERCENT ARE BLACK; 35.7 PERCENT ARE HISPANIC; 22.5 PERCENT ARE WHITE; THREE PERCENT ARE ASIAN/PACIFIC ISLANDER/NATIVE AMERICAN. THE UCP ARE COMMITTED TO WORKING CLOSELY WITH PROVIDERS AND INDIVIDUALS TO SUPPORT ACCESS TO THE WIDE RANGE OF OPTIONS FOR PAYMENT FOR HEALTH CARE SERVICES AND MEDICATIONS FOR PERSONS LIVING WITH OR AT RISK OF ACQUIRING HIV. THE UCP HAVE EXPLORED WAYS TO OVERCOME BARRIERS TO RAPID ACCESS TO TREATMENT AND ONGOING CARE. ACKNOWLEDGING THE CRITICAL NEED FOR RAPID ACCESS TO ARV THERAPY, THE UCP REVISED THE ENROLLMENT PROCESS TO FACILITATE SAME-DAY ENROLLMENT AND RAPID ACCESS TO TREATMENT. IN 2020, THE UCP IMPLEMENTED AN ON-LINE PORTAL THAT ALLOWS FOR THE SECURE SUBMISSION OF PROGRAM APPLICATIONS AND RECERTIFICATION DOCUMENTS. THE ON-LINE PROCESS STREAMLINES CURRENT ENROLLMENT AND RECERTIFICATION PROCESSES AND WILL SUPPORT RAPID ACCESS TO TREATMENT FOR PERSONS LIVING WITH HIV BY ALLOWING APPLICANTS TO SECURELY COMPLETE AND SUBMIT THE APPLICATION AND SUPPORTING DOCUMENTATION FOR INITIAL APPLICATION AND RECERTIFICATION DOCUMENTATION AS NEEDED. THE UCP RESPONDED TO THE COVID-19 PUBLIC HEALTH EMERGENCY WITH NO DISRUPTION IN SERVICES FOR UNINSURED AND UNDERINSURED PERSONS LIVING WITH HIV. THE UCP HAS DEVELOPED A PROGRAM-SPECIFIC CASCADE OF CARE WHICH DEMONSTRATES THAT THE PROGRAMS HAVE BEEN SUCCESSFUL IN LINKING UNINSURED AND UNDERINSURED PERSONS TO CONTINUOUS CARE AND ACHIEVING VIRAL SUPPRESSION. NINETY PERCENT OF PROGRAM PARTICIPANTS WHO WERE ACTIVE IN THE PROGRAM FOR AT LEAST ONE YEAR ARE IN CONTINUOUS CARE. NINETY-FIVE PERCENT ARE VIRALLY SUPPRESSED.
990, PART III, LINE 4B. PUBLIC HEALTH EMERGENCY AND HOSPITAL PREPAREDNESSTHE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) PUBLIC HEALTH EMERGENCY PREPAREDNESS (PHEP) AND THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE (ASPR) HOSPITAL PREPAREDNESS PROGRAM (HPP) FUNDING THROUGH HRI SUPPORTS THE EFFORTS OF THE NEW YORK STATE DEPARTMENT OF HEALTH (NYSDOH) OFFICE OF HEALTH EMERGENCY PREPAREDNESS (OHEP). OHEP CONTINUES TO WORK WITH THE STATE OFFICE OF EMERGENCY MANAGEMENT (STATE OEM) AND OTHER STATE AGENCIES, LOCAL HEALTH DEPARTMENTS (LHD) AND PRIVATE AND PUBLIC-SECTOR PARTNERS TO BUILD A SOLID EMERGENCY PREPAREDNESS AND RESPONSE FOUNDATION TO RESPOND TO ANY CRISIS OR EMERGENT SITUATION IN THE STATE. BASED ON AN ASSESSMENT OF NYSDOH CAPABILITIES AND GAPS, NYSDOH HAS CAREFULLY REVIEWED ITS PROGRESS IN DESIGNING AN INTEGRATED AND COMPREHENSIVE HEALTH EMERGENCY PREPAREDNESS STRUCTURE AND HAS STRATEGICALLY PRIORITIZED FUTURE EFFORTS. 1. HRI/NYSDOH OHEP CONTINUES TO SUSTAIN ITS FULLY DEVELOPED INCIDENT MANAGEMENT SYSTEM (IMS). ACCOMPLISHMENTS FROM THE PERIOD 04/01/2020 TO 03/31/2021 HRI/NYSDOH OHEP WORKED WITH HEALTH EMERGENCY PREPAREDNESS COALITION (HEPC) LEADERSHIP AND A MULTIDISCIPLINARY GROUP OF COMMUNITY PARTNERS TO DEVELOP THE NYSDOH PEDIATRIC SURGE ANNEX TO THE HEALTH EMERGENCY PREPAREDNESS AND RESPONSE PLAN (HEPRP). HRI/NYSDOH OHEP PARTICIPATED IN AN ANNUAL MULTI-YEAR TRAINING AND EXERCISE PROGRAM (MYTEP) MEETING WHICH IDENTIFIED NYSDOH AND OTHER STATE AGENCY TRAINING AND EXERCISE ACTIVITIES TO BUILD AND SUSTAIN CAPABILITIES OVER THE NEXT FIVE YEARS. HRI/NYSDOH OHEP IDENTIFIED EFFORTS TO SUPPORT RECOVERY SUPPORT FUNCTIONS (RSF) AND THE COORDINATING AGENCIES TO BE INCLUDED IN THE STATE EMERGENCY OPERATIONS CENTER (EOC) EMERGENCY SUPPORT FUNCTION (ESF) REPRESENTATIVE STANDARD OPERATING PROCEDURE (SOP). HRI/NYSDOH OHEP TRAINED AN ADDITIONAL THIRTY (30) IMS PERSONNEL IN EOC AND ESF OPERATIONS FOR A TOTAL OF 84 TRAINED STAFF. TRAININGS IMPROVED NYSDOH COORDINATION AND PLANNING FOR LARGE-SCALE EMERGENCIES INCLUDING DURING COVID-19 RESPONSE. HRI/NYSDOH OHEP IDENTIFIED STRENGTHS AND AREAS FOR IMPROVEMENT THROUGH EXERCISE AND UPDATED THE HEALTH OPERATIONS CENTER (HOC) SOP. HRI/NYSDOH OHEP TRAINED HEPC LEADS AND CONTRACTED HEALTHCARE ASSOCIATIONS IN GENERAL EMERGENCY MANAGEMENT ASSISTANCE COMPACT (EMAC) POLICIES AND PROCEDURES WITH CONSIDERATION FOR PUBLIC HEALTH BEST PRACTICES. 2. HRI/NYSDOH OHEP CONTINUES TO SUPPORT AND PROVIDE UPDATED GUIDANCE FOR DISTRIBUTION AND DISPENSING OF MEDICAL COUNTERMEASURES (MCM), INCLUDING VACCINES AND MEDICATIONS, USING LOCAL POINTS OF DISPENSING (POD)/CLINIC OPERATIONS. NYSDOH OHEP HAS FOCUSED ON RESEARCHING ALTERNATE DISPENSING STRATEGIES SUCH AS CLOSED POD PARTNERSHIPS, THAT MAY INCLUDE PRIMARY CARE PROVIDERS, HEALTHCARE FACILITIES, PHARMACIES AND PRIVATE BUSINESS LOCATIONS. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2020 TO 03/31/2021 CLINICAL GUIDANCE UPDATES TO SAFELY AND RAPIDLY PROVIDE MCM DURING POD WERE INCLUDED IN ALL 57 LHD CLINICAL OPERATIONS PLANS. LHDS IDENTIFIED LANGUAGE ACCESS SERVICES TO INCLUDE IN THEIR MCM DISPENSING PLANS. HRI/NYSDOH OHEP IDENTIFIED STRENGTHS AND AREAS FOR IMPROVEMENT THROUGH EXERCISE AND LHDS SUBMITTED AFTER-ACTION REPORT/IMPROVEMENT PLANS AND UPDATED THEIR MCM PLANS. 3. HRI/NYSDOH CONTINUES TO SUPPORT THE MEDICAL EMERGENCY RESPONSE INVENTORY TRACKING SYSTEM (MERITS). MERITS IS AN ELECTRONIC INVENTORY MANAGEMENT SYSTEM THAT SUPPORTS THE STRATEGIC NATIONAL STOCKPILE (SNS) AND THE STATE'S MEDICAL EMERGENCY RESPONSE CACHE (MERC) WAREHOUSE OPERATIONS. THIS INCLUDES PROCESSING ORDERS, RECEIVING, SHIPPING, REPORTING AND MAINTAINING A MASTER INVENTORY OF ALL ASSETS. NYSDOH OHEP CONTINUES TO SUSTAIN MEDICAL MATERIEL MANAGEMENT AND DISTRIBUTION CAPACITY TO RESPOND TO A PUBLIC HEALTH THREAT WITH MCM AND/OR DURABLE MEDICAL EQUIPMENT TO PROVIDE FOR A TIMELY AND EFFECTIVE RESPONSE. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2020 TO 03/31/2021 HRI/NYSDOH INFORMATICS STAFF CONDUCTED FIVE (5) MERITS TRAININGS FOR HEPCS AND LHDS. MERC INVENTORY WAS REPLENISHED. 4. HRI/NYSDOH CONTINUES TO SUPPORT INFORMATICS INFRASTRUCTURE TO PROVIDE ELECTRONIC, SECURE SYSTEMS AND APPLICATIONS FOR EMERGENCY PREPAREDNESS, RESPONSE AND RECOVERY. HRI/NYSDOH WILL SUSTAIN AND IMPROVE SYSTEMS FOR INFORMATION EXCHANGE. IN-PLACE ARCHITECTURE WAS LEVERAGED, AND NEW COMPONENTS WERE ADDED THAT LINK NYSDOH WITH ITS EMERGENCY PREPAREDNESS AND RESPONSE PARTNERS AND PROMOTE THE EXCHANGE OF DATA WITH STAKEHOLDERS, BI-DIRECTIONALLY, WHILE ENSURING APPROPRIATE PRIVACY PROTECTION. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2020 TO 03/31/2021 HRI/NYSDOH INFORMATICS IDENTIFIED STRENGTHS AND GAPS OF INFORMATION COLLECTED IN THE IMS DASHBOARD, WHICH IS USED TO FORM A COMMON OPERATING PICTURE (COP) DURING EMERGENCY EVENTS, TO GUIDE ONGOING APPLICATION DEVELOPMENT. HRI/NYSDOH INFORMATICS ENSURED ACCURACY OF GEOGRAPHIC INFORMATION SYSTEM (GIS) DATA PRESENTED IN EMERGENCY RESPONSE APPLICATIONS AND MAPPING TOOLS FOR REAL-TIME SITUATIONAL AWARENESS DURING EMERGENCIES AND EXERCISES. HRI/NYSDOH TRAINED 75% OF THE STATE, REGIONAL AND LOCAL PARTNERS ON HEALTH COMMERCE SYSTEM (HCS), HEALTH ELECTRONIC RESPONSE DATA SYSTEM (HERDS) AND INTEGRATED HEALTH ALERTING NETWORK SYSTEM (IHANS). HRI/NYSDOH COUNTERMEASURES DATA MANAGEMENT SYSTEM (CDMS) WORKGROUP IDENTIFIED FUNCTIONS OF THE APPLICATION FOR IMPROVEMENT TO ENHANCE USER ACCESSIBILITY AND FUNCTIONALITY. 100% OF REGIONAL OFFICES AND IDENTIFIED NYSDOH IMS LEADS SUBMITTED A SITUATION REPORT USING THE VIRTUAL HEALTH OPERATION CENTER (VHOC) APPLICATION. ACKNOWLEDGEMENT OF RECEIPT OF COMMUNICATIONS DURING EXERCISES AND HEALTH EMERGENCY RESPONSES INCREASED BY 20% ACROSS PARTNER TYPES. 5. HRI/NYSDOH CONTINUES TO SUSTAIN AND BUILD PUBLIC HEALTH LABORATORY TESTING CAPABILITY OF THE NYSDOH WADSWORTH CENTER (WC), TO INCLUDE TESTING OF CLINICAL, ENVIRONMENTAL, FOOD AND WATER SAMPLES. LABORATORY TESTING CONTINUES TO BE A PRIORITY AREA INCLUDING COORDINATION AND COMMUNICATION EFFORTS AND BUILDING ADDITIONAL CAPABILITIES. LABORATORY RESPONSE NETWORK (LRN)-BIOLOGICAL (B) GOALS INCLUDE RAPID TESTING USING LRN PROTOCOLS AND REPORTING TO SUBMITTERS TO PROVIDE INFORMATION FOR PROMPT DECISION MAKING. LRN-B WILL SUSTAIN THE ABILITY FOR CONTACTING THE SENTINEL LABORATORIES IN NEW YORK STATE (NYS) THROUGH THE HCS. LRN-CHEMICAL (C) GOALS INCLUDE THE ADOPTION OF TECHNOLOGY TO PROCESS AND MAINTAIN THE POSITIVE IDENTIFICATION OF THE LARGE NUMBER OF SPECIMENS THAT ARE HANDLED DURING SURGE TESTING AND TO USE THE REFERENCE MATERIALS THAT ARE NOW SUPPLIED BY THE CDC FOR METHOD IMPROVEMENT AND THE FULL VALIDATION OF ANALYTICAL PROTOCOLS. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2020 TO 03/31/2021 THE LRN-C MAINTAINED QUALIFIED STATUS THROUGH ACHIEVING A 100% PASSING RATE ON PROFICIENCY TESTING FOR FIVE (5) LRN CORE METHODS (HNPAA, OPNA, NITROGEN MUSTARD, ABRINE, RICININE). THE LRN-C ACHIEVED QUALIFIED STATUS THROUGH ACHIEVING A 100% PASSING RATE ON PROFICIENCY TESTING FOR NEW LRN-C ANALYTES, SBMSE. THE LRN-C RESPONDED TO SPHLS WITHIN THREE (3) BUSINESS DAYS FOR TECHNICAL ASSISTANCE (TA) WITH THE NEW ANALYTES URINE MERCURY AND SBMSE IN URINE/SERUM. THE LRN-C SHIPPED TEN (10) CHALLENGE SAMPLES FOR EACH PROFICIENCY TESTING (PT) EVENT, THREE (3) TIMES A YEAR, TO UP TO 30 SPHLS. THE LRN-C SHIPPED KITS CONTAINING THREE (3) LEVELS OF QUALITY ASSURANCE (QA) MATERIALS TO UP TO 30 SPHLS FOR USE IN MAINTAINING THEIR CORE METHODS FOR THE TOXIC METALS SCREEN PANEL AND MERCURY IN URINE. 100% OF ALL SAMPLES SUSPICIOUS FOR AGENTS ON THE LRN REQUALIFICATION LIST TESTED WITHIN TWO (2) HOURS OF RECEIPT BY LRN-B. THE WADSWORTH CENTER PROVIDED UPDATED INFORMATION THAT DETAILS THE REQUIREMENTS FOR PACKAGING AND SHIPPING OF CLINICAL SPECIMENS FOR BIOLOGICAL AND CHEMICAL TESTING AS NEEDED TO ENSURE PROMPT AND CONFORMING SUBMISSION OF SPECIMENS FOR ANALYSIS. 95% OF THE LAW ENFORCEMENT, EMERGENCY MEDICAL SERVICES (EMS), FIRE AND HAZMAT PERSONNEL WHO ATTENDED THE TRAINING ARE COMPETENT IN THE COLLECTION, PACKAGING AND TRANSPORT OF SUSPICIOUS BIOLOGICAL AND CHEMICAL AGENTS. 100% OF SAMPLES RECEIVED BY NYSDOH LRN-B WERE APPROPRIATELY PACKAGED FOR RECEIPT. THE LRN-C PRODUCED AN APPROVED STANDARD OPERATING PROCEDURES MANUAL (SOPM) THAT MEETS THE CLINICAL LABORATORY IMPROVEMENT AMENDMENT (CLIA) REQUIREMENTS AND PARTICIPATED IN ALL ROUND ROBINS AND/OR SPLIT SAMPLES CONSISTENT WITH CDC LRN-C EXPECTATIONS. 6. THE HRI/NYSDOH CONTINUES TO SUSTAIN AND ENHANCE ITS COMMUNICABLE DISEASE SURVEILLANCE SYSTEMS THAT COLLECT INFORMATION FROM MULTIPLE DATA STREAMS DAILY TO ENSURE A BASELINE OF EPIDEMIOLOGIC DATA FOR NYS. NYSDOH CONTINUES TO SUSTAIN THE CAPABILITY TO ANALYZE AND INTERPRET EPIDEMIOLOGIC DATA THAT IS CRITICAL TO THE PRACTICE OF PUBLIC HEALTH.
990, PART III, LINE 4B. PUBLIC HEALTH AND CARE EMERGENCY PREPAREDNESSPREPARDNESS CONTD. ACCOMPLISHMENTS FROM THE PERIOD 04/01/2020 TO 03/31/2021 100% OF CATEGORY I DISEASE REPORTS HAD AN INVESTIGATION INITIATED WITHIN 24 HOURS. 90% OF CATEGORY II DISEASE REPORTS HAD AN INVESTIGATION INITIATED WITHIN THREE (3) BUSINESS DAYS. 85% OF CATEGORY III DISEASE REPORTS HAD AN INVESTIGATION INITIATED WITHIN FIVE (5) BUSINESS DAYS. 100% OF CATEGORY A DISEASE INVESTIGATIONS WERE COMPLETED. 90% OF CATEGORY B DISEASE INVESTIGATIONS WERE COMPLETED. 85% OF CATEGORY C DISEASE INVESTIGATIONS WERE COMPLETED. 100% OF NOTIFIABLE DISEASES REPORTED TO CDC USING DISEASE-SPECIFIC HL7 MESSAGING. 100% OF OUTBREAKS/EVENTS DETECTED USING ADVANCED ANALYTICS TO START COMMUNICABLE DISEASE INVESTIGATIONS AND IMPLEMENTATION OF APPROPRIATE CONTROL MEASURES. 100% OF NOTIFIABLE DISEASES REPORTED THROUGH NSSP ESSENCE TOOL FOR EARLY DETECTION AND RAPID ASSESSMENT OF BIOTERRORISM-RELATED EVENTS NATIONWIDE. HRI/NYSDOH EPIDEMIOLOGY IS DEVELOPING INDIVIDUALIZED REPORTS FOR ALL 57 LHDS TO RECEIVE AND COMPARE ACHIEVEMENT WITH OTHER COUNTIES WITHIN THE SAME GEOGRAPHIC REGION AND SIMILAR POPULATION SIZE TO FORM A COP OF DISEASE SURVEILLANCE STATEWIDE. PROGRAM PERIOD SUCCESSES: COVID-19 RESPONSE HRI/NYSDOH STAFF, FUNDED BY FEDERAL GRANTS OR OTHER NON-STATE APPOINTED POSITIONS, WERE REASSIGNED TO SUPPORT NUMEROUS COVID-19 RESPONSE ACTIVITIES, INCLUDING, INCIDENT MANAGEMENT COORDINATION, STAFFING THE STATE OEM ESF-8 (PUBLIC HEALTH AND MEDICAL) AND ESF-6 (MASS CARE, EMERGENCY ASSISTANCE, HOUSING AND HUMAN SERVICES) DESKS, DRIVE-THROUGH DIAGNOSTIC SWABBING OPERATIONS, SEROLOGY TEST SITES, CALL CENTERS, AIRPORTS AND TRAIN STATIONS FOR SCREENING OF TRAVELERS COMING INTO NEW YORK STATE (NYS) FROM RESTRICTED STATES WITH WIDESPREAD COMMUNITY TRANSMISSION OF COVID-19 AND THE STATE RUN VACCINATION SITES. NYSDOH DEVELOPED AND DISTRIBUTED DOCUMENTS AND PROTOCOLS, INCLUDING FREQUENTLY ASKED QUESTIONS (FAQ) SHEETS, INFECTION CONTROL GUIDANCE DOCUMENTS AND ADVISORIES FOR LHDS HEALTHCARE PARTNERS. NYSDOH STAFF PROVIDED LEADERSHIP AND OVERSIGHT FOR THE IMPLEMENTATION OF NON-PHARMACEUTICAL INTERVENTIONS (NPI), ISOLATION AND QUARANTINE, MEDICAL SURGE, EDUCATION LIAISING, PERSONAL PROTECTIVE EQUIPMENT (PPE) SHORTAGES, MOVEMENT MONITORING, CLEANING, DISINFECTION, CLINICAL UPDATES AND FOR THE ROLLOUT OF VACCINE OPERATIONS. NYSDOH GENERATED INVENTORY REPORTS USING MERITS TO QUICKLY ASSESS STOCKPILED SUPPLY OF PPE AND DURABLE MEDICAL EQUIPMENT, INCLUDING VENTILATORS, IN THE MERC WAREHOUSES AND PRIORITIZE AND EXPEDITE PURCHASES DURING NATIONWIDE SUPPLY CHAIN SHORTAGES. NYSDOH MONITORED INVENTORY IN THE MERC WAREHOUSES AND REPLENISHED AS NEEDED TO MAINTAIN SUPPLY FOR THE DURATION OF THE RESPONSE. HRI/NYSDOH INFORMATICS SUSTAINED EMERGENCY RESPONSE SYSTEMS, SUPPORTED DAILY HERDS SURVEYS, AND PROVIDED ON-CALL SERVICES FOR IHANS BROADCAST NOTIFICATIONS INCLUDING DAILY MONITORING OF EDUCATIONAL INSTITUTIONS AND THE HOSPITAL SURGE AND FLEX OPERATION. SUPPORTING STATE MASS VACCINATION SITES WAS A SIGNIFICANT FOCUS DURING THIS PERIOD, BOTH ONSITE AND REMOTELY. MASS VACCINATION SITES REQUIRED DAILY ADDITIONS AND MODIFICATIONS TO THE SUPPORT ELECTRONIC SYSTEMS DUE TO CONTINUING IDENTIFICATION OF SYSTEM REQUIREMENTS NECESSARY TO IMPROVE THE EFFICIENCY OF VACCINATION OPERATIONS. NYSDOH INFORMATICS CREATED CALL CENTER FUNCTIONALITY TO ASSIST NYS RESIDENTS WHO COULD NOT REGISTER ONLINE, MADE CHANGES TO THE BACKEND SERVERS AND SYSTEMS TO HANDLE THE HIGH VOLUME OF USERS, MODIFIED THE DATA TRANSFER PROCESS OF CDMS TO NEW YORK STATE IMMUNIZATION INFORMATION SYSTEM (NYSIIS) FROM MANUAL TO AUTOMATED AND MADE ADDITIONAL CHANGES AS REQUESTED BY STATE AND DOH EXECUTIVES. NYSDOH INFORMATICS ESTABLISHED A SUPPORT BRIDGE TO MANAGE HCS REQUESTS NEEDED AT THE STATE MASS VACCINATION SITES THAT ARE OPERATING SEVEN (7) DAYS A WEEK. NYSDOH PUBLIC AFFAIRS GROUP (PAG) WORKED WITH THE GOVERNOR'S OFFICE TO PROVIDE NEW YORKERS WITH COMPREHENSIVE DAILY MESSAGING TO REDUCE THE IMPACT OF COVID-19. THIS INCLUDED PARTICIPATION IN NEWS BRIEFINGS, PROACTIVELY INTERACTING WITH THE MEDIA, CREATING NEW PUBLIC SERVICE ANNOUNCEMENTS, MAINTAINING A COVID-19 WEBSITE AND SHARING INFORMATIONAL RESOURCES WITH LHD AND HEALTH CARE ORGANIZATIONS. ALTHOUGH PLANNING HAS CONCENTRATED MORE ON VACCINE DISTRIBUTION AND DISPENSING FROM JANUARY TO MARCH 2021, NYS AND LHD PARTNERS CONTINUED TO EMPHASIZE THE BASICS OF NPIS INCLUDING MASK WEARING AND SOCIAL DISTANCING, ESPECIALLY SINCE MULTIPLE COVID-19 VARIANTS WERE IDENTIFIED IN NYS. ADDITIONALLY, OTHER NPIS ARE STILL IN PLACE AND CONTINUING, INCLUDING AIRPORT SCREENINGS AND CONTACT TRACING. THESE EFFORTS EXEMPLIFY THE PARTNERSHIPS BETWEEN NYSDOH AND THE LHDS TO ENSURE MEASURES ARE TAKEN FROM CASE IDENTIFICATION TO CLEARANCE OF ISOLATION AND QUARANTINE INTERVENTIONS WITHIN THE COMMUNITY. INCREASED COMMUNICATION BETWEEN EPIDEMIOLOGY, CLUSTER RESPONSE TEAMS, AND THE LABORATORY ALLOWED FOR SCHEDULING AND CONTROL OF SPECIMENS SENT TO THE WADSWORTH CENTER FOR TESTING. THE USE OF MULTIPLE TESTING PLATFORMS ALLOWED THE LAB TO PROVIDE RAPID TESTING TURNAROUND TIME WITHOUT INTERRUPTION THROUGHOUT THE PANDEMIC. CROSS TRAINING AND UTILIZATION OF WADSWORTH CENTER PERSONNEL OUTSIDE OF THE VIROLOGY LABORATORY ALLOWED THE LAB TO PROVIDE INCREASED TESTING CAPACITY. ESTABLISHED COMMUNICATION BETWEEN THE LABORATORY AND PARTNERS SUCH AS THE NYS DEPARTMENT OF CORRECTIONS AND COMMUNITY SUPERVISION (DOCCS), NY REGIONAL EPIDEMIOLOGY OFFICES, NURSING HOMES, AND VETERANS' HOMES ALLOWED WADSWORTH CENTER TO RECEIVE REMOTE ORDERS FOR TESTING WHICH ASSISTED LABORATORY WORKFLOW AND PROVIDED AN INCREASED RAPID TURNAROUND TIME. THE LABORATORY WAS ALSO ABLE TO PROVIDE SPECIMEN SHIPPERS TO PARTNERS INCREASING BIOSAFETY PRACTICES AS THESE BOXES WERE IN SHORT SUPPLY THROUGHOUT THE STATE. THE LAB IS PERFORMING VALIDATION AND VERIFICATION STUDIES TO BEGIN MULTIPLEX TESTING.
FORM 990, PART III, LINE 4C, CANCER RESEARCHROSWELL PARK CANCER INSTITUTE IS A MULTIDISCIPLINARY, TRANSLATIONAL COMPREHENSIVE CANCER CENTER, WITH A MISSION TO ELIMINATE CANCER'S GRIP ON HUMANITY BY UNLOCKING ITS SECRETS THROUGH PERSONALIZED APPROACHES AND UNLEASHING THE HEALING POWER OF HOPE. RPCI UTILIZES ITS COMPREHENSIVE CANCER SUPPORT GRANT (CCSG) THROUGH HRI TO BUILD ON UNIQUE STRENGTHS AND OPPORTUNITIES, MOVING LABORATORY SCIENCE INTO ADVANCED TREATMENT, PREVENTION, DIAGNOSIS, AND EDUCATION. ROSWELL PARK CANCER INSTITUTE'S REVOLUTIONARY RESEARCH MODEL OF A "MULTIDISCIPLINARY APPROACH" TO CANCER WITH SCIENTISTS AND CLINICIANS WORKING IN CONCERT AND IN CONSULT HAS BECOME THE STANDARD BY WHICH ALL MODERN-DAY COMPREHENSIVE CANCER CENTERS ARE MEASURED. HRI CONTINUES TO WORK WITH RPCI LEADERSHIP IN ALL OF THEIR RESEARCH ENDEAVORS. HRI'S CANCER RESEARCH GRANT PORTFOLIO SUPPORTS A NATIONALLY RECOGNIZED RESEARCH ENTERPRISE AT RPCI. THE BUFFALO COMPREHENSIVE CANCER CENTER IS RANKED 14TH AND IS ONE OF ONLY 50 COMPREHENSIVE CANCER CENTERS IN THE COUNTRY. HEALTH RESEARCH INCORPORATED (HRI) PROVIDES EFFECTIVE PRE- AND POST-AWARD EVALUATION, SOLICITATION, AND ADMINISTRATION OF EXTERNAL RESEARCH SUPPORT FROM FEDERAL AND STATE AGENCIES, NOT FOR-PROFIT FOUNDATIONS, AND COMMERCIAL FIRMS IN ACCORDANCE WITH THE REQUIREMENTS OF THE SPONSOR. THE HRI/GRANTS MANAGEMENT STAFF (22 FTES) SUPPORT MORE THAN 541 ACTIVE GRANTS ANNUALLY FOR RPCI, PROVIDING TIMELY AND DETAILED GRANT REVENUE AND EXPENDITURE INFORMATION FOR INTERNAL AND EXTERNAL REVIEW, AS WELL AS ANALYSIS WITH INSTITUTE INVESTIGATORS. HRI'S SUPERIOR GRANT ADMINISTRATION EXPERTISE AND ITS ABILITY TO ATTRACT HIGHLY QUALIFIED RESEARCH STAFF HAVE CONTRIBUTED TO THE CONTINUED UPWARD TRAJECTORY OF THE INSTITUTION AND ITS CANCER RESEARCH. HRI-ROSWELL PARK DIVISION CURRENTLY HAS 541 ACTIVE PROJECTS TOTALING $99.0 MILLION, OF WHICH $66.3 MILLION ARE PEER REVIEWED AWARDS. HRI-ROSWELL PARK'S LARGEST SPONSOR IS THE NATIONAL INSTITUTE OF HEALTH (NIH) REPRESENTING 60% OF TOTAL FUNDING. HRI-ROSWELL PARK DIVISION RECEIVED MORE THAN $117.6 MILLION OF REVENUE IN FY21.
FORM 990, PART III, LINE 4D. OTHER PROGRAM SERVICESBIOMEDICAL RESEARCH PUBLIC AFFAIRS GROUP HEALTH FACILITIES MANAGEMENT SCHOOL OF PUBLIC HEALTH DIVISION OF ADMINISTRATION AND INFORMATION SYSTEM TECHNOLOGY TRANSFER, INTERNALLY SPONSORED RESEARCH AND PUBLIC HEALTH PROGRAMS OFFICE OF PUBLIC HEALTH PROGRAMS AND RESEARCH CENTER FOR ENVIRONMENTAL HEALTH AND RESEARCH OFFICE OF HEALTH SYSTEM MANAGEMENT DIVISION OF HEALTH CARE STANDARDS SURVEY DIVISION OF HEALTH FACILITY PLANNING OFFICE OF HEALTH INSURANCE PROGRAMS OFFICE OF QUALITY AND PATIENT SAFETY
FORM 990, PART VI, SECTION B, LINE 11BTHE ANNUAL FORM 990 IS INITIATED BY THE CORPORATE CONTROLLER AND DEVELOPED IN CONJUNCTION WITH THE ASSISTANT DIRECTOR OF FINANCE AND OPERATIONS AND THE EXECUTIVE DIRECTOR. THE FINAL DRAFT IS REVIEWED BY THE THREE KEY PERSONNEL LISTED ABOVE. A COMPARATIVE ANALYSIS TO THE PRIOR YEAR'S FILING IS CONDUCTED AND THEN THE FINAL DRAFT IS PRESENTED TO HEALTH RESEARCH, INC'S INDEPENDENT AUDIT FIRM FOR VALIDATION. ONCE FINALIZED BY THE INDEPENDENT AUDIT FIRM, THE EXECUTIVE DIRECTOR PRESENTS AND REVIEWS THE FORM 990 FILING WITH THE CORPORATION'S SECRETARY/TREASURER AND IF REQUESTED, THE CORPORATION'S VICE PRESIDENT. A COPY OF THE 990 IS PROVIDED TO ALL DIRECTORS OF THE HRI BOARD FOR THEIR REVIEW PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12CHRI CONFLICT OF INTEREST POLICIES ARE REVIEWED ANNUALLY AND IF APPROPRIATE, REVISED BY THE CORPORATION'S HOUSE COUNSEL AND EXECUTIVE DIRECTOR. THE MOST RECENT VERSION OF THE HRI EMPLOYEE CONFLICT OF INTEREST POLICY WAS UPDATED IN JANUARY 2018. THE POLICY IS PROVIDED TO EMPLOYEES ON AN ANNUAL BASIS VIA HRI'S ONLINE TRAINING SYSTEM. INDIVIDUALS ARE REQUIRED TO ATTEST TO READING THE POLICY; CONFIRMATION OF WHICH IS ELECTRONICALLY MAINTAINED BY CORPORATE HUMAN RESOURCE STAFF. IN ADDITION TO THE ANNUAL CERTIFICATION, ALL NEW EMPLOYEES ARE PROVIDED WITH A COPY OF EMPLOYEE CONFLICT OF INTEREST POLICY IN CONJUNCTION WITH NEW HIRE ORIENTATION, AND THE POLICY IS AVAILABLE ON THE HRI WEBSITE. ALL POTENTIAL CONFLICTS MUST BE DISCLOSED IN WRITING TO THE CORPORATE OFFICE FOR REVIEW AND CONSIDERATION BY MANAGEMENT. COMPLIANCE WITH THE PROVISIONS OF THE POLICY ARE MONITORED AND ENSURED THROUGH THE PRESENCE OF COMPLIMENTARY CONTROLS, SUCH AS THE HRI OUTSIDE EMPLOYMENT POLICY AND HONORARIA/TRAVEL EXPENSE REIMBURSEMENT POLICY. ANNUALLY, MEMBERS OF THE BOARD OF DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE PROVIDED WITH A COPY OF THE CONFLICT OF INTEREST POLICY FOR BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES AND MUST CERTIFY THAT THEY HAVE READ AND UNDERSTAND THE POLICY, IN ADDITION TO DISCLOSING ALL CONFLICTS OF INTEREST. NEW HRI BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES ARE PROVIDED WITH A COPY OF THE POLICY AT THE TIME OF APPOINTMENT AND ARE REQUIRED TO DISCLOSE ANY CONFLICTS UPON RECEIPT. ATTESTATIONS AND DISCLOSURE FORMS ARE SENT TO THE HRI CORPORATE OFFICE AND THEN FORWARDED TO THE AUDIT COMMITTEE FOR REVIEW AND CONSIDERATION. THE ORGANIZATION IS CONTINUING TO ENHANCE ITS PROCESS TO ENSURE THAT ALL CONFLICT OF INTEREST CERTIFICATIONS ARE DOCUMENTED. RESTRICTIONS IMPOSED ARE CONDITIONED AND DETERMINED BY CIRCUMSTANCES AND RANGE FROM DENIAL OF THE REQUEST FOR AN EMPLOYEE TO RECUSAL FOR A DIRECTOR OF THE CORPORATION.
FORM 990, PART VI, SECTION B, LINE 15SALARIES OF THE EXECUTIVE DIRECTOR AND ALL KEY EMPLOYEES ARE SET IN THE ANNUAL BUDGET. THIS IS REVIEWED AND APPROVED BY THE BOARD ANNUALLY.
FORM 990, PART VI, SECTION C, LINE 19HEALTH RESEARCH, INC.'S GOVERNING DOCUMENTS: CONFLICT OF INTEREST POLICY, ETHICS POLICY, WHISTLEBLOWER POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
990, PART X INVESTMENTS PUBLICLY TRADED SECURITIESDESCRIPTION ENDING BOOK VALUE COST OF FMV US TREASURIES & SECURITIES $572,410,944 FMV TOTALS $572,410,944
990, PART XII, LINE 2CTHERE HAVE BEEN NO CHANGES MADE TO THE OVERSIGHT AND SELECTION PROCESS DURING THE TAX PREP YEAR.